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Abstract
Avicins, a family of triterpene electrophiles originally identified as potent inhibitors of tumor cell growth, have been shown
to be pleiotropic compounds that also possess antioxidant, anti-mutagenic, and anti-inflammatory activities. We previously
showed that Jurkat cells, which express a high level of Fas, are very sensitive to treatment with avicins. Thus, we
hypothesized that avicins may induce cell apoptosis by activation of the Fas pathway. By using a series of cell lines deficient
in cell death receptors, we demonstrated that upon avicin D treatment, Fas translocates to the cholesterol- and
sphingolipid-enriched membrane microdomains known as lipid rafts. In the lipid rafts, Fas interacts with Fas-associated
death domain (FADD) and Caspase-8 to form death-inducing signaling complex (DISC) and thus mediates cell apoptosis.
Interfering with lipid raft organization by using a cholesterol-depleting compound, methyl-b-cyclodextrin, not only prevents
the clustering of Fas and its DISC complex but also reduces the sensitivity of the cells to avicin D. Avicin D activates Fas
pathways independent of the association between extracellular Fas ligands and Fas receptors. A deficiency in Fas and its
downstream signaling molecules leads to the resistance of the cells to avicin D treatment. Taken together, our results
demonstrate that avicin D triggers the redistribution of Fas in the membrane lipid rafts, where Fas activates receptor-
mediated cell death.
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Introduction
The Fas death receptor (CD95 or APO-1) conveys apoptotic
signals through binding to its cognate ligand, FasL (CD95L), making
the interaction between FasL and Fas a potential tumor-fighting
target. Unfortunately, the putative clinical antitumor action of FasL
cannot be reached because of severe liver toxicity due to the high
expression of Fas on the surface of hepatocyte [1]. Recent evidence
for a FasL-independent activation of Fas suggests that the death
receptor can also be activated intracellularly, in the absence of its
ligand [2]. Unraveling the mechanisms could provide the basis for
novel therapeutic strategies for various diseases and could aid in the
development of new compounds able to exploit cytoplasmic triggers
of apoptosis for clinical use. This is of importance in apoptosis-
deficient disorders such as cancer [2] and autoimmune diseases [3].
Fas-mediated apoptosis involves translocation of Fas–and its
downstream signaling molecules into lipid rafts, a process that can
be pharmacologically modulated [2]. FasL-independent clustering
of Fas in membrane rafts generates high local concentrations of
death receptors, providing scaffolds for coupling the adaptor and
effector proteins involved in Fas-mediated apoptosis [4]. Thus,
lipid rafts act as the linchpin from which a potent death signal is
launched, suggesting a promising new target for anticancer
therapeutics. These findings have revealed a novel framework
for the development of more targeted therapies leading to
intracellular Fas activation and for the recruitment of downstream
signaling molecules into Fas-enriched lipid rafts [2,3,4].
Avicins, a family of triterpene electrophiles, selectively inhibit
the growth of various tumor cells [5,6,7,8]. Avicins activate the
intrinsic caspase pathway to induce apoptosis by direct perturba-
tion of mitochondria, and downregulate a group of pro-survival,
anti-apoptotic proteins, including HSP-70, XIAP, PI3K, AKT,
and NF-kB [6,7,8,9,10]. We further showed in a recent report that
avicins can induce not only apoptotic cell death but also
autophagic programmed cell death by depletion of the cell energy
supply, suggesting a potential therapeutic application of avicins in
apoptosis-resistant cancers [11]. In addition to their cytotoxic
properties, avicins possess cyto-protective effects against non-
transformed cells, in part related to the activation of the
transcription factor Nrf-2 [12]. Activation of proteins downstream
of Nrf2, such as glutathione peroxidase, heme oxygenase, and
thioredoxin reductase, accounts in part for the antioxidant, anti-
mutagenic and tissue protective effects of avicins in vitro and in
vivo [9,12,13,14]. The studies indicated that avicins, multifunc-
tional compounds, not only inhibit tumor cell growth but may play
a role in the maintenance of cellular homeostasis as well.
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levels of Fas are very sensitive to avicin treatment [6]. Thus, we
hypothesized that avicins may induce apoptosis by activation of
the Fas pathway. In the present study, with a series of cell lines
deficient in cell death receptors, we demonstrated that upon avicin
D treatment, Fas translocates to lipid rafts, where it associates with
Fas-associated death domain (FADD) and Caspase-8 to form
death-inducing signaling complex (DISC), and thus mediates cell
apoptosis.
Materials and Methods
Cell Lines
U2OS, Daudi, NB4, and parental Jurkat Human cell lines were
purchased from ATCC. U2OS (osteosarcoma) cells were grown in
Dulbecco modified Eagle medium (DMEM) containing 10% fetal
bovine serum (FBS) in a humidified incubator containing 5% CO2
at 37uC. The human leukemia cell lines, Daudi, NB4, and
parental Jurkat cells and those deficient in Fas [2], FADD [15],
Caspase-8 [15], and receptor interacting protein (RIP) [16] were
cultured in RPMI 1640 medium containing 10% FBS.
Antibodies and Chemicals
Antibodies against Caspase-3, Caspase-7, FADD, RIP, Poly
(ADP-ribose) polymerase (PARP), and Bid were purchased from
BD Biosciences (San Diego, CA). Anti-Fas (human, activating)
antibody (clone CH11) and anti-Fas (human, neutralizing)
antibody (clone ZB4) were purchased from Millipore (Billerica,
MA). The activating anti-Fas antibody was used to induce Jurkat
cell apoptosis at 10 mg/ml. The neutralizing anti-Fas antibody
(50 ng/ml) was used to block Jurkat cell apoptosis. Caspase-8 and
inhibitor of caspase-activated DNase (ICAD)/DNA-fragmentation
factor 45 (DFF-45) were purchased from Upstate Biotechnology
Inc. (Lake Placid, NY). Anti-tumor necrosis factor a (TNFa) and
anti-cellular FLICE-inhibitory protein (c-FLIP) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-a-tubulin monoclonal antibody and Anti-b-actin polyclonal
antibody were purchased from Sigma Aldrich (St. Louis, MO) and
Bethyl Laboratories (Montgomery, TX), respectively. Methyl-b-
cyclodextrin, fluorescein isothiocyanate (FITC)-cholera toxin B
subunit (FITC-CTXb), and CTXb subunit conjugated to
horseradish peroxidase were purchased from Sigma Aldrich.
Avicin D and avicin G were purified from A. victoriae root
extracts as described in our recent report [17].
Cell Death and Viability Assay
Cell death was examined by the cell death enzyme-linked
immunosorbent assay (ELISA) according to the manufacturer’s
protocol of Roche Diagnostics (Pleasanton, CA) or by trypan blue
exclusion kit from Sigma-Aldrich (St. Louis, MO) [18]. Cell
viability was measured by a CellTiter-Glo Luminescent Cell
Viability Assay kit from Promega Corp (Madison, WI) per the
manufacturer’s protocol and by trypan blue exclusion assay [11].
Flow Cytometry Analysis of DNA Content
For flow cytometry (FCM) analysis of the DNA content, cells
were treated, collected, and fixed in 70% ethanol for at least 24 h.
The cells were then resuspended in phosphate-buffered saline
(PBS), treated with 2 N HCl containing 0.2 mg/ml pepsin, and
neutralized with 0.1 M sodium tetraborate. Following washes with
PBS, cells were incubated in RNase A (0.5 mg/ml) and propidium
iodide (50 mg/ml) diluted to an equal concentration and analyzed
by FCM [18].
Isolation of Lipid Rafts by Discontinuous Sucrose
Gradient Centrifugation
Lipid rafts were isolated by using lysis conditions and
centrifugation on discontinuous sucrose gradients as previously
reported [2]. Briefly, 16108 Jurkat cells were washed with ice-cold
PBS and lysed for 30 min on ice in 1% Triton X-100 in TNEV
buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA,
1 mM sodium orthovanadate) containing 1 mM phenylmethyl-
sulfonyl fluoride. Cells were then homogenized with 10 strokes in a
Potter-Elvehjem tissue grinder (Vernon Hills, Illinois). Nuclei and
cellular debris were pelleted by centrifugation at 1000 rpm for
8 min. Then, 1 mL of cleared supernatant was mixed with 1 mL
of 85% sucrose in TNEV and transferred to the bottom of a
Beckman 14695-mm centrifuge tube. The diluted lysate was
overlaid with 6 mL of 35% sucrose in TNEV and, finally, with
4 mL of 5% sucrose in TNEV. The samples were centrifuged in
an SW40 rotor at 38 000 rpm for 18 h at 4uC in a Beckman
Optima LE-80K ultracentrifuge (Beckman Instruments, Palo Alto,
CA), and then 0.75-mL fractions were collected from the top of the
gradient.
To determine the location of lipid rafts and Fas and its
downstream targets in the discontinuous sucrose gradient, 25 mL
of the individual fractions were subjected to 12% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and im-
munoblotted with different antibodies. The location of the lipid
rafts was determined by a dot blot using the CTXb subunit
conjugated to horseradish peroxidase.
Immunofluorescent Staining and Fluorescent Microscope
Immunofluorescent staining was performed in accordance with
procedures described previously [19]. Briefly, Jurkat cells were
cyto-spun to a microscope slide with the Shandon CytoSpin III
Cytocentrifuge (Ramsey, Minnesota). The cells were then fixed in
4% neutral paraformaldehyde for 30 min, washed in PBS,
permeabilized in a solution containing 0.1% Triton X-100/
0.05% NP40/PBS, and blocked with 1% bovine serum albumin
(BSA). Cells were incubated with anti-Fas antibody and CTx B-
FITC for 2 h and then allowed to interact with a rhodamine
conjugated secondary antibody for 1 h at room temperature,
followed by staining of the DNA with 49,6-diamidino-2-pheny-
lindole (DAPI) for 5–10 min. Fluorescent signaling was observed
with a Nikon Eclipse TE2000-E fluorescent microscope.
Immunoblotting
Cell lysis and immunoblotting were performed as described
previously [19]. A total of 50 mg of protein was used for the
immunoblotting (unless otherwise indicated). b-actin or a-tubulin
was used for the loading control.
Results
Avicin D Activates Cell Apoptosis Mediated by Fas–
Caspase-8
To investigate whether avicins can induce cell death via
activation of the death receptor–Caspase-8 pathway, we exposed
Jurkat cells and a promyelocyte leukemia cell line, NB4 cells, to
various concentrations of avicin D for 24–72 h and analyzed the
viability and activation of the Caspase-8 pathway. Consistent with
our previous reports [6], avicin D treatment resulted in substantial
cell death (Figure 1A, C). After exposure to 0.5 mg/ml of avicin D
for 72 h, 70% of the NB4 cells and 90% of the Jurkat cells
committed to cell death (Figure 1A, C), and cell viability was
significantly inhibited (Figure 1B, D). Avicin D induced cell death
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PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8532Figure 1. Avicin D activates Caspase-8–mediated cell death. Proliferating Jurkat cells were exposed to different doses of avicin D for 24–72 h.
A. Cell death was measured by trypan blue exclusion assay. The number of dead cells was counted as a percentage of total cells. B. Cell viability was
measured by a CellTiter-Glo Luminescent Cell Viability Assay kit. Data are shown as mean6S.D. (n=5). The number of surviving cells was counted as a
percentage of total cells. C and D. Cell death and cell viability were measured in NB4 cells exposed to 0–4 mg/ml of avicin D for 24–48 h as described
in the Methods. Data are shown as mean6S.D. (n=3). The number of dead or surviving cells was counted as a percentage of total cells. E.
Proliferating Jurkat cells were exposed to 2 mg/ml of avicin D for 24 h. Cleavage of Caspase-8 induced by avicin D was analyzed by Western blot.
50 mg of total protein were loaded in each lane. a-Tubulin was detected to serve as an internal control. F. Time-dependent activation of Caspase-8
and apoptotic regulators in avicin D-treated Jurkat and NB4 cells. G. Time-dependent activation of Caspase-8 and apoptotic regulators in avicin D-
treated U2OS cells.
doi:10.1371/journal.pone.0008532.g001
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(Figure 1A–D). Interestingly, avicin D treatment also led to an
elevated cleavage of Caspase-8, an important indicator of death
receptor-induced apoptosis (Figure 1E). The activation of Caspase-
7 and ICAD/DFF-45, two downstream targets of the death
receptor–Caspase-8 pathway [20], was also induced by this
treatment with avicin D (Figure 1E). The activation of Caspase-
8 and its downstream targets was induced as early as 8 h after
avicin D treatment (Figure 1F). The time-dependent activation of
Caspase-8 by treatment with avicin D was also confirmed in a
human osteosarcoma cell line, U2OS (Figure 1G). Taken together,
these data suggest that avicin D-mediated cell death is associated
with the activation of the death receptor–Caspase-8 pathway.
Cell Apoptosis Induced by Avicin D and Mediated by
Fas–Caspase-8 Is Independent of Extracellular Fas
Activation
To determine whether avicin D-induced Caspase-8 activation
and cell apoptosis are associated with extracellular Fas activation,
we pretreated Jurkat cells with neutralizing anti-Fas antibody for
2 h. Neutralizing anti-Fas antibody blocks extracellular activation
signaling, such as that of Fas ligands and activating antibodies, and
inhibits the apoptosis induced by these factors. We then treated the
cells with avicin D. The enrichment of nucleosomes from the
cytoplasmic fraction (DNA fragmentation) in Jurkat cells treated
with the neutralizing anti-Fas antibody and avicin D existed no
significant difference compared to that of avicin D treatment
alone, indicating that the neutralizing anti-Fas antibody did not
block avicin D-induced cell death (Figure 2A). In contrast, the
neutralizing anti-Fas antibody completely blocked the activation of
cell death as mediated by cytotoxic anti-Fas CH11 antibodies
(Figure 2A). Consistent with the results of the DNA fragmentation
assay, neutralizing anti-Fas antibody could not improve the
viability of cells treated with avicin D either (Figure 2B).
Flow cytometry analysis of sub-G1/G0 cells is an important
indicator by which to divide apoptotic cells from cells
undergoing other types of death. To confirm the apoptotic
nature of the cell death induced by avicin D and neutralizing
anti-Fas antibodies is not sufficient to block avicin D’s effects, we
pre-treated Jurkat cells with 50 ng/ml neutralizing anti-Fas
antibody for 2 h. We then treated the cells with either avicin D
or activating anti-Fas antibody. Although the neutralizing anti-
Figure 2. Avicin D-induced cell death is not via an extracellular mechanism. Proliferating Jurkat cells were pretreated with activating anti-
Fas antibody (A), neutralizing anti-Fas antibody (N), activating and neutralizing anti-Fas antibody (A+N), or TNFa for 2 h, followed by avicin D (2 mg/
ml) for 24 h. A. Cell death was quantified using a cell death ELISA showing the enrichment of nucleosomes in the cytoplasmic fraction of Jurkat cells.
Values represent the mean6S.D. (n=3). B. Cell viability was measured by a CellTiter-Glo Luminescent Cell Viability Assay kit. Data are shown as
mean6S.D. (n=4). The number of surviving cells was counted as a percentage of total cells. C. Apoptosis and cell-cycle distribution of Jurkat cells
treated with avicin D and/or anti-Fas antibodies and TNFa. Flow cytometry (FCM) analysis was carried out to detect sub-G1 (apoptotic cells) and other
cell-cycle distributions. The numbers in parenthesis are the percentage of sub-G1. Representative FCM graphs of three experiments are shown.
doi:10.1371/journal.pone.0008532.g002
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(distribution of sub-G1/G0 phase cells) induced by activating
anti-Fas antibody, it did not block the avicin D-induced cell
apoptosis (Figure 2C). Together, our results suggest that avicin
D-induced cell apoptosis mediated by Fas–Caspase-8 is inde-
pendent of extracellular Fas activation.
Avicin D Induces the Clustering of Fas into Lipid Rafts
Lipid rafts on the cell membrane have been reported to play an
important role in the activation of death receptors [3,21,22]. To
determine whether lipid rafts might serve as a platform for avicin D
to induce Fas–Caspase-8 activation and apoptosis, we exposed
Jurkat cells to 2 mg/ml of avicin D for 0–8 h and detected the
distribution of lipid rafts and translocation of Fas by immunoflu-
orescence. Membrane rafts were assessed by the FITC-CTx B
subunit marker that binds ganglioside GMi, which mainly exists in
rafts [23]. In the control experiment of Jurkat cells without any
treatment, lipid rafts distributed on the cell membrane evenly
(Figure 3A). Fas receptors located on the cell membrane showed less
colocalization with lipid rafts (Figure 3A9,A 0). In contrast, following
treatment with avicin D, lipid rafts clustered and formed a ‘‘cap-
like’’ structure at one pole of the cells, which happened within 2 h
after the treatment (Figure 3B–D). Avicin D treatment also led to
the aggregation of Fas although it occurred after the clustering of
lipid rafts (Figure 3B9–D9). Importantly, engaged Fas co-localized
with lipid rafts (Figure 3B0–D0). In addition to Fas, Jurkat cells also
express several other types of death receptors, such as TNFR1 and
TRAIL/DR5. We next questioned whether avicin D could also
trigger other death receptors translocated to lipid rafts. Our results
showed that avicin D did not induce the engagement and
translocation of TNFR1 and TRAIL/DR5 to lipid rafts (data not
shown),which isconsistent with thecomponentanalysisoflipid rafts
extracted with a discontinuous sucrose density gradient centrifuga-
tion (see below for details). Collectively, our results suggest that
avicin Dinducestheclusteringoflipid raftsandspecificallymediates
the recruitment of Fas into lipid rafts.
Avicin D-Induced Apoptosis Is Dependent upon Lipid
Rafts
To further confirm that the apoptosis induced by avicin D in
Jurkat cells is associated with the engagement and recruitment of
Fas into lipid rafts, we investigated cell apoptosis and lipid raft
formation in Jurkat cells pretreated with an agent that disrupts lipid
rafts, methyl-b-cyclodextrin (MCD) [24]. The disruption of lipid
raftscausedbya 1 h pretreatment with2.5 mg/mlMCD prevented
avicin D-induced apoptosis (Figure 4A). Pretreatment with MCD
also remarkably increased the viability of avicin D-treated Jurkat
cells (Figure 4B). MCD blocked avicin D-induced cell apoptosis and
extended cell viability in a dose-dependent manner, with the
maximum effect being seen after treatment with 2.5 mg/ml of
MCD (approximately 80% reversal of apoptosis) (Figure 4C and
other data not shown). MCD disorganized the clustering of lipid
rafts that had been induced by avicin D and disrupted the
aggregation and translocation of Fas into lipid rafts (Figure 4D). To
eliminate the possibility that extracellular interactions between
MCD and avicin D were reducing the cytotoxicity of avicin D, we
pre-exposed Jurkat cells and Daudi cells to 2.5 mg/ml MCD for
8 h, and avicin D was supplied after the MCD was washed off the
Figure 3. Avicin D induces clustering of Fas in lipid rafts. Jurkat cells were treated with 2 mg/ml of avicin D for 0–8 h. After the treatment, the
cells were fixed and stained with FITC-CTxB subunits to identify lipid rafts (green fluorescence) and with anti-Fas antibodies to identify Fas (red
fluorescence). Area of colocalization between membrane rafts and Fas in the merge panels is yellow.
doi:10.1371/journal.pone.0008532.g003
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avicin D-induced cell apoptosis. Cell apoptosis (sub-G1) was
significantly reduced in both Jurkat and Daudi cells (data not
shown). Collectively, our results suggest that the clustering of Fas-
containing lipid rafts is required for avicin D to induce apoptosis.
Cell Membrane Integrity Is Necessary for Avicin D to
Function
To further confirm that the integrity of cell membrane, where
lipid rafts are located, is required for avicin D-mediated cell
apoptosis,we cultured Jurkat and Daudi cells in serum-free medium
Figure 4. Avicin D-induced apoptosis is lipid raft-dependent. (A & B) Proliferating Jurkat cells were pretreated with 2.5 mg/ml of MCD for 1 h,
followed by 2 mg/ml of avicin D for 24 h. A. Cell death was quantified using a cell death ELISA showing enrichment of nucleosomes in the cytoplasmic
fraction of Jurkat cells. Values represent the mean6S.D. (n=3). B. Cell viability was determined by trypan blue exclusion assay. The number of
surviving cells was counted as a percentage of total cells. C. MCD inhibits the activity of avicin D in a dose-dependent manner. Increasing
concentrations of MCD were applied to Jurkat cells. One hour after treatment with MCD, 2 mg/ml of avicin D were added to the medium. Cell viability
was determined by trypan blue exclusion assay after 24 h. Jurkat cells without treatment with MCD and avicin D were set as 100%. D. Jurkat cells
were pretreated with 2.5 mg/ml MCD for 1h, followed by 2 mg/ml avicin D for 8 h. The cells were then fixed and stained with FITC-CTxB subunits to
identify rafts (green fluorescence) and with anti-Fas antibody to identify Fas (red fluorescence). Area of colocalization between membrane rafts and
Fas in the merge panels is yellow.
doi:10.1371/journal.pone.0008532.g004
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with cholesterol to build up lipid rafts in cell membranes. As shown
in Figure 5A and 5C, 36% of the Jurkat cells treated with 2.0 mg/
ml avicin D for 24 h in regular cell culture medium (10% serum)
committed to apoptosis (distributed in the sub-G1 phase). In
contrast, only 7% of the cells treated with avicin D in serum-free
medium exhibited apoptosis, suggesting that depletion of serum
(cholesterol) could block avicin D-mediated cell apoptosis. By using
the avicin D-sensitive human lymphoma cell line, Daudi, we
obtained the same results as shown in the Jurkatcells (Figure 5B–D).
Taken together, our results suggest that the integrity of the cell
membrane with functional lipid rafts plays an important role in
avicin D-induced cell apoptosis.
Avicin D Recruits Fas and Its Downstream Signaling
Molecules into Lipid Rafts
To further confirm the translocation of Fas and its downstream
signaling molecules into lipid rafts, we isolated membrane rafts in
both untreated and avicin D-treated Jurkat cells in the presence or
absence of MCD. Lipid rafts were isolated based on their
Figure 5. The integrity of the cell membrane is needed for the function of avicin D. Proliferating Jurkat (A, C) and Daudi (B, D) cells were
pretreated with methyl-b-cyclodextrin (MCD) for 8 h. After washing away the MCD, cells were exposed to 2 mg/ml Avicin D for 24 h in DMEM medium
with or without 10% FCS. Cells were fixed and stained with PI. Flow cytometry analysis was carried out to detect sub-G1 (apoptotic cells) and cell
cycle distribution. A. Percentage of sub-G1 Jurkat cells after the treatment. Data shown are means6S.D. of three independent experiments. B.
Percentage of sub-G1 Daudi cells after the treatment. Data shown are means6S.D. of three independent experiments. C. Representative FCM graphs
of Jurkat cells after the treatment. D. Representative FCM graphs of Daudi cells after the treatment.
doi:10.1371/journal.pone.0008532.g005
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sucrose density gradients. The location of the lipid rafts was
determined by horseradish peroxidase-conjugated CTx B subunits
that bind ganglioside GMi, which mainly exists in rafts [22,23]. As
shown in Figure 6A, GM1 was enriched in fractions 5–9 of the
sucrose gradient. In control cells, Fas, FADD, Caspase-8, Caspase-
7, Bid, and TNFa-R1 were mainly in the soluble parts of the
isolate (fractions 10–14) and were not co-fractioned with GM1,
suggesting that these components are not in lipid rafts normally.
After treatment with avicin D, however, Fas, FADD, Caspase-8,
Caspase-7, and Bid were recruited into the lipid raft region
(fractions 5–9) of the sucrose gradient (Figure 6A, right panels).
Interestingly, two additional major death receptors, TNFa-R1 and
DR5, were not translocated to rafts after the avicin D treatment
(Figure 6A and other data not shown), suggesting that the
translocation of Fas and its downstream targets were a specific
process triggered by avicin D.
In contrast, pretreatment with 2.5 mg/ml of MCD completely
abrogated the translocation of the apoptotic signaling molecules
regardless of the presence or absence of avicin D (Figure 6B),
which further supports our conclusion that avicin D-induced
apoptosis is dependent upon lipid rafts and that the integrity of
these rafts plays a critical role in avicin D-mediated cell death.
Aberrations in Fas and Its Downstream Signaling
Molecules Abrogate the Effects of Avicin D
Since Fas-mediated apoptosis plays an important role in avicin
D-induced apoptosis, we next questioned whether depletions of
Fas or its downstream targets would reduce the effects of avicin D
on cell death. Parental and Fas-, FADD-, Caspase-8–, and RIP-
Figure 6. Avicin D recruits Fas and its downstream signaling molecules into lipid rafts. Proliferating Jurkat cells were pretreated with or
without 2.5 mg/ml MCD for 1 h, followed by 2 mg/ml Avicin D for 24 h. After the treatment, the cells were lysed in 1% Triton X-100 and subjected to
discontinuous sucrose density gradient centrifugation. Components in each fraction were analyzed by Western blot. Location of lipid rafts was
determined by a dot blot using CTxB subunits conjugated to horseradish peroxidase. A. Components of lipid rafts in control and avicin D-treated
Jurkat cells. B. Components of lipid rafts in MCD with/without avicin D-treated Jurkat cells.
doi:10.1371/journal.pone.0008532.g006
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Treatment with avicin D led to a remarkable activation of
Caspase-7, Caspase-3, and PARP in parental Jurkat cells
(Figure 7A). By contrast, deficiency of Fas [2], FADD [15],
Caspase-8 [15], and RIP [16] reduced the activation of Caspase-7,
Caspase-3, and PARP mediated by avicin D (Figure 7A), thus
reduced avicin D-mediated apoptosis substantially (Figure 7B-C).
Interestingly, in the Fas-FADD-Caspase-8 cell death pathway, the
further upstream the deficiency happens, the more resistant the
cells are to treatment with avicin D (Figure 7B–C). These results
unambiguously prove that Fas and its downstream signaling
targets are critical mediators of avicin D-induced cell death.
Discussion
Lipid rafts are enriched membrane microdomains that contain
high concentrations of cholesterol and glycosphingolipids, which
are resistant to solubilization by detergents and represent areas of
reduced fluidity plane of the lipid bilayer [23,25]. A variety of
proteins, especially those involved in cell signaling, have been
shown to translocate into lipid rafts. As a result, lipid rafts are
thought to be involved in the regulation of signal transduction.
Experimental evidence suggests that there are probably several
different mechanisms through which rafts control cell signaling.
For example, rafts may contain incomplete signaling pathways
that are activated when a receptor or other required molecule is
recruited into the raft. Rafts may also be important in limiting
signaling, either by physical sequestration of signaling components
to block nonspecific interactions, or by suppressing the intrinsic
activity of signaling proteins present within the rafts.
Death receptors, which include Fas (CD95), TNFR1, and
TRAIL (R2/DR5) [20,26], are an important family of proteins
that locate on the cell membrane. While the roles of lipid rafts in
the function of many membrane receptors have been increasingly
clear [4,24,27,28], their importance to death-receptor signaling
remains controversial. The discrepancies in the models proposed
by different groups focus on whether death receptors are recruited
to the lipid rafts and how the death receptors are organized in the
lipid rafts if they are indeed aggregated therein.
Fas triggers cell death through the presence of a death domain
in its cytoplasmic portion after receptor engagement with FasL or
agonistic anti-Fas antibodies [29]. Stimulation of Fas results in the
oligomerization of its receptors and the recruitment of the adaptor
molecule FADD through the interaction of death domains from
both parts, which results in the recruitment of procaspase-8 and
the formation of DISC. The proximity of procaspase-8 molecules
in the DISC drives its activation by self-cleavage, triggering
downstream effector caspases and leading to apoptosis [20,29].
Thus, formation of membrane platforms where Fas molecules are
brought together may increase DISC formation and, therefore,
potentiate Fas signaling. In this regard, lipid rafts may provide
microdomains for the interaction of Fas cell death complexes and
play a role in mediating Fas-induced cell death.
Our results showed that avicin D induce caspase-8-mediated
cell apoptosis. Theoretically, activation of Caspase-8 may be
mediated through Fas, TNFR1, or TRAIL-R2/DR5 receptors
pathways [20]. Avicin D-induced activation of Caspase-8 may
involve some or all of these receptors. It is known that stimulation
of TNFR1 induces the activation of caspase-8 and NF-kB
simultaneously. Our previous study reported that treatments with
avicins lead to the inhibition of NF-kB and its associated functions
[9]. Thus, avicin D-induced activation of caspas-8 is unlikely
through the stimulation of TNFR1. In addition, our functional
assay showed that avicin D exerted a synergistic effect with TNFa
and TRAIL (data not shown), indicating that the action of avicin
D is independent of TNFR1 and TRAIL-R2/DR5. Therefore, we
conclude that avicin D-induced Caspase-8 activation and cell
apoptosis are mainly associated with Fas receptors.
Importantly, we found that components of the DISC complex
can be found in lipid rafts after treatment with avicin D, and that
the efficient induction of apoptosis by avicin D is dependent upon
intact lipid rafts and the integrity of the Fas signaling pathway.
Disruption of lipid raft organization by the cholesterol-depleting
compound MCD not only abolishes the clustering of Fas and its
DISC complex, but reduces avicin D-induced cell apoptosis as
well. Interestingly, avicin D-induced activation of the Fas pathway
is not dependent on the linkage of extracellular Fas ligands or the
application of agonist Fas antibodies, suggesting that avicin D may
incorporate into cell membrane rafts, promoting their clustering as
well as the translocation of Fas and its downstream signaling
molecules into clustered rafts.
Although the exact mechanism by which avicin D induces
cholera toxin capping and Fas recruitment to lipid rafts remains
elusive, our data indeed indicate that avicin D rapidly induces
membrane rafts, which aggregate at the cell surface. Fas and its
downstream effectors are recruited into these rafts enriched in
apoptotic signaling molecules, which appear to function as
platforms to elicit an efficient apoptotic response. Thus, the
recruitment of Fas and its downstream effectors into membrane
rafts may provide a mechanism for amplifying Fas signaling by
reorganizing membrane microdomains and bringing molecules
together in a well-defined and reduced space, facilitating
interactions among different signaling molecules and pathways
[30]. Our results suggest that such rafts might be targets for
therapeutic intervention. However, the results reported here also
indicate that in the absence of Fas, the clustering of these rafts is
not sufficient to mount an apoptotic response in avicin D-treated
cells (Figure 7). Thus, rafts behave as recruitment platforms to
facilitate and potentiate downstream signaling events, with Fas
functioning as a critical trigger of the apoptotic process.
We previously reported that avicin parental compound F094,
which includes avicin D, avicin G, and some other unknown
components, can inactivate AKT [6]. As PI3K inhibition is known
to induce Fas activation and is Fas-ligand independent [31], this
might raise the concern that avicin D activates Fas separate of its
ability to induce cholera toxin capping and recruitment of Fas and
toxin to detergent resistant membrane fractions. However, we
found that inactivation of AKT by avicin parental compound
F094 is a later effect, 24–48 hrs after the exposure. In this study,
we showed that avicin D-mediated clustering of lipid rafts and
activation of Fas took place as early as 2–4 hrs after the treatment
(Figure 3). In addition, as one of the components in avicin parental
compound F094, avicin D has only a marginal effect on AKT
inactivation [11]. Most importantly, blockage of lipid raft
organization via the depletion of cholesterol by MCD substantially
prevents avicin D-mediated Fas activation and cell apoptosis
(Figure 4). Taken together, these data provide unambiguous
evidences to prove that avicin D-induced cell apoptosis is a direct
accomplishment of lipid microdomain reorganization and Fas
activation.
The clinical usefulness of exogenous activation of Fas, as well as
of the other major death receptors (i.e., TNF and TRAIL
receptors) by their respective ligands or agonists has been
hampered by toxic side effects [16,21,32,33]. Systemic adminis-
tration of TNF causes a severe inflammatory response syndrome
that resembles septic shock [34]. Likewise, the administration of
the agonistic antibody to Fas in mice causes lethal liver failure
through massive hepatocyte apoptosis [35].
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PLoS ONE | www.plosone.org 9 December 2009 | Volume 4 | Issue 12 | e8532Figure 7. Aberrations in Fas and its downstream signaling molecules abrogate the effects of avicin D. Parental Jurkat cells and Fas-,
FADD-, Caspase-8-, and RIP-deficient Jurkat cells were treated with 2 mg/ml of Avicin D for 24 h. A. Detection of apoptotic molecules by Western blot.
50 ı `g of total protein were loaded in each lane. b-Actin was detected to serve as an internal control. B. The percentage of apoptotic cells. After the
treatment, the cells were fixed and stained with PI. Flow cytometry (FCM) analysis was performed to detect sub-G1 (apoptotic cells). C. Representative
FCM graphs of parental, Fas-deficient, and RIP-deficient Jurkat cells.
doi:10.1371/journal.pone.0008532.g007
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PLoS ONE | www.plosone.org 10 December 2009 | Volume 4 | Issue 12 | e8532However, our studies showed that non-transformed normal cells
are resistant to avicin D treatment [6]. This may be due to the fact
that avicin D does not activate Fas extracellularly, but from an
intracellular FasL-independent manner. The compound may be
taken up by tumor cells but not by normal cells because of a
possible difference between the membranes of normal and
malignant cells. A variation in the permeability of these cells to
avicin D may account for the failure to trigger the ensuing
apoptotic events.
In this regard, avicin D may lead to the use of raft-dependent
and intracellularly activated Fas-mediated killing in cancer
chemotherapy, representing a new way to target tumor cells.
Further elucidation of the mechanisms regulating avicin D uptake,
intracellular Fas activation, and the formation of rafts may lead to
the development of novel cancer therapeutic strategies that have
few or no adverse effects on normal tissues.
Acknowledgments
We really appreciate Dr. F. Mollinedo for providing Fas-deficient Jurkat
cells and Dr. B. Seed for providing parental and RIP-deficient Jurkat cells.
We thank Dr. J. Y. Liang for his helpful discussion.
Author Contributions
Conceived and designed the experiments: Z-XX JUG. Performed the
experiments: Z-XX TD FC. Analyzed the data: Z-XX VH JUG.
Contributed reagents/materials/analysis tools: TD. Wrote the paper:
Z-XX.
References
1. Schattenberg JM, Galle PR, Schuchmann M (2006) Apoptosis in liver disease.
Liver Int 26: 904–911.
2. Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, et al. (2004)
Intracellular triggering of Fas aggregation and recruitment of apoptotic
molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med
200: 353–365.
3. Kabouridis PS, Jury EC (2008) Lipid rafts and T-lymphocyte function:
implications for autoimmunity. FEBS Lett 582: 3711–3718.
4. Scheel-Toellner D, Salmon M, Lord JM (2003) A life-raft for death signaling?
Cancer Biol Ther 2: 396–397.
5. Haridas V, Kim SO, Nishimura G, Hausladen A, Stamler JS, et al. (2005)
Avicinylation (thioesterification): a protein modification that can regulate the
response to oxidative and nitrosative stress. Proc Natl Acad Sci U S A 102:
10088–10093.
6. Mujoo K, Haridas V, Hoffmann JJ, Wachter GA, Hutter LK, et al. (2001)
Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell
proliferation and induce apoptosis. Cancer Res 61: 5486–5490.
7. Haridas V, Higuchi M, Jayatilake GS, Bailey D, Mujoo K, et al. (2001) Avicins:
triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by
mitochondrial perturbation. Proc Natl Acad Sci U S A 98: 5821–5826.
8. Gaikwad A, Poblenz A, Haridas V, Zhang C, Duvic M, et al. (2005)
Triterpenoid electrophiles (avicins) suppress heat shock protein-70 and x-linked
inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin
machinery: implications for proapoptotic activity. Clin Cancer Res 11:
1953–1962.
9. Haridas V, Arntzen CJ, Gutterman JU (2001) Avicins, a family of triterpenoid
saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-
kappaB by inhibiting both its nuclear localization and ability to bind DNA. Proc
Natl Acad Sci U S A 98: 11557–11562.
10. Gutterman JU, Lai HT, Yang P, Haridas V, Gaikwad A, et al. (2005) Effects of
the tumor inhibitory triterpenoid avicin G on cell integrity, cytokinesis, and
protein ubiquitination in fission yeast. Proc Natl Acad Sci U S A 102:
12771–12776.
11. Xu ZX, Liang J, Haridas V, Gaikwad A, Connolly FP, et al. (2007) A plant
triterpenoid, avicin D, induces autophagy by activation of AMP-activated
protein kinase. Cell Death Differ 14: 1948–1957.
12. Haridas V, Hanausek M, Nishimura G, Soehnge H, Gaikwad A, et al. (2004)
Triterpenoid electrophiles (avicins) activate the innate stress response by redox
regulation of a gene battery. J Clin Invest 113: 65–73.
13. Hanausek M, Ganesh P, Walaszek Z, Arntzen CJ, Slaga TJ, et al. (2001) Avicins,
a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-
ras mutations and aneuploidy in a murine skin carcinogenesis model. Proc Natl
Acad Sci U S A 98: 11551–11556.
14. Blackstone NW, Kelly MM, Haridas V, Gutterman JU (2005) Mitochondria as
integrators of information in an early-evolving animal: insights from a
triterpenoid metabolite. Proc Biol Sci 272: 527–531.
15. Juo P, Woo MS, Kuo CJ, Signorelli P, Biemann HP, et al. (1999) FADD is
required for multiple signaling events downstream of the receptor Fas. Cell
Growth Differ 10: 797–804.
16. Pimentel-Muinos FX, Seed B (1999) Regulated commitment of TNF receptor
signaling: a molecular switch for death or activation. Immunity 11: 783–793.
17. Li XX, Davis B, Haridas V, Gutterman JU, Colombini M (2005) Proapoptotic
triterpene electrophiles (avicins) form channels in membranes: cholesterol
dependence. Biophys J 88: 2577–2584.
18. Xu ZX, Zhao RX, Ding T, Tran TT, Zhang W, et al. (2004) Promyelocytic
leukemia protein 4 induces apoptosis by inhibition of survivin expression. J Biol
Chem 279: 1838–1844.
19. Xu ZX, Timanova-Atanasova A, Zhao RX, Chang KS (2003) PML colocalizes
with and stabilizes the DNA damage response protein TopBP1. Mol Cell Biol
23: 4247–4256.
20. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770–776.
21. Muppidi JR, Siegel RM (2004) Ligand-independent redistribution of Fas (CD95)
into lipid rafts mediates clonotypic T cell death. Nat Immunol 5: 182–189.
22. Patra SK (2008) Dissecting lipid raft facilitated cell signaling pathways in cancer.
Biochim Biophys Acta 1785: 182–206.
23. Brown DA (2006) Lipid rafts, detergent-resistant membranes, and raft targeting
signals. Physiology (Bethesda) 21: 430–439.
24. Scheel-Toellner D, Wang K, Assi LK, Webb PR, Craddock RM, et al. (2004)
Clustering of death receptors in lipid rafts initiates neutrophil spontaneous
apoptosis. Biochem Soc Trans 32: 679–681.
25. Hanzal-Bayer MF, Hancock JF (2007) Lipid rafts and membrane traffic. FEBS
Lett 581: 2098–2104.
26. Edinger AL, Thompson CB (2004) Death by design: apoptosis, necrosis and
autophagy. Curr Opin Cell Biol 16: 663–669.
27. Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest
110: 597–603.
28. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol
Cell Biol 1: 31–39.
29. Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16: 139–144.
30. Lincoln JE, Boling M, Parikh AN, Yeh Y, Gilchrist DG, et al. (2006) Fas
signaling induces raft coalescence that is blocked by cholesterol depletion in
human RPE cells undergoing apoptosis. Invest Ophthalmol Vis Sci 47:
2172–2178.
31. Be ´ne ´teau M, Pizon M, Chaigne-Delalande B, Daburon S, Moreau P, et al.
(2008) Localization of Fas/CD95 into the lipid rafts on down-modulation of the
phosphatidylinositol 3-kinase signaling pathway. Mol Cancer Res 6: 604–13.
32. Mollinedo F, Gajate C (2006) Fas/CD95 death receptor and lipid rafts: new
targets for apoptosis-directed cancer therapy. Drug Resist Updat 9: 51–73.
33. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, et al. (2000) Apoptosis induced
in normal human hepatocytes by tumor necrosis factor-related apoptosis-
inducing ligand. Nat Med 6: 564–567.
34. Watanabe S, Mukaida N, Ikeda N, Akiyama M, Harada A, et al. (1995)
Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2
through inhibiting production and action of TNF. Int Immunol 7: 1037–1046.
35. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T,
et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:
806–809.
Avicin D Induces Apoptosis
PLoS ONE | www.plosone.org 11 December 2009 | Volume 4 | Issue 12 | e8532